Insights

Innovative Product Portfolio Epredia's diversified portfolio of ground-breaking cancer diagnostics solutions, including digital pathology and laser slide printers, positions it as a leader in precision medicine, offering ample opportunities to cross-sell and upsell advanced diagnostic tools to healthcare providers seeking cutting-edge technologies.

Award-Winning Recognition Recent multiple awards and industry accolades, notably for AI-assisted pathology solutions and scanner benchmarks, enhance Epredia’s credibility and appeal to hospitals and labs investing in validated, innovative diagnostic technologies.

Strategic Global Expansion With a strong global presence and partnerships with distributors like Abacus dx and NovaScan, Epredia is well-positioned to accelerate market penetration in emerging regions and tap into international healthcare markets seeking advanced cancer diagnostic solutions.

Technological Leadership Epredia's adoption of advanced tech stacks and AI integration in pathology diagnostics signals its commitment to innovation, presenting opportunities for sales teams to highlight value in future digital and automation enhancements to progressive healthcare facilities.

Strong Market Position Epredia’s impressive revenue range and strategic acquisitions from Thermo Fisher Scientific provide a stable financial foundation, indicating capacity for expanded sales initiatives, especially targeting large hospitals and pathology labs aiming to upgrade their diagnostic infrastructure.

Epredia Tech Stack

Epredia uses 8 technology products and services including Twitter Ads, Power BI, SAP, and more. Explore Epredia's tech stack below.

  • Twitter Ads
    Advertising
  • Power BI
    Business Intelligence
  • SAP
    Customer Relationship Management
  • JD Edwards
    Enterprise
  • JavaScript
    Programming Languages
  • PRINCE2
    Project Management
  • Autoptimize
    Web Platform Extensions
  • Apache
    Web Servers

Media & News

Epredia's Email Address Formats

Epredia uses at least 1 format(s):
Epredia Email FormatsExamplePercentage
First.Last@epredia.comJohn.Doe@epredia.com
83%
First_Last@epredia.comJohn_Doe@epredia.com
11%
FirstLast@epredia.comJohnDoe@epredia.com
4%
FirLast@epredia.comJohDoe@epredia.com
2%

Frequently Asked Questions

Where is Epredia's headquarters located?

Minus sign iconPlus sign icon
Epredia's main headquarters is located at 20 Post Road Portsmouth, New Hampshire 03801 United States. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Epredia's stock symbol?

Minus sign iconPlus sign icon
Epredia is a publicly traded company; the company's stock symbol is EPAM.

What is Epredia's official website and social media links?

Minus sign iconPlus sign icon
Epredia's official website is epredia.com and has social profiles on LinkedIn.

What is Epredia's SIC code NAICS code?

Minus sign iconPlus sign icon
Epredia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Epredia have currently?

Minus sign iconPlus sign icon
As of March 2026, Epredia has approximately 733 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Commercial Officer (cco) & Chief Strategy Officer (cso): B. L.Chief Manufacturing Officer -Emea: I. W.Vice President Finance: C. K.. Explore Epredia's employee directory with LeadIQ.

What industry does Epredia belong to?

Minus sign iconPlus sign icon
Epredia operates in the Biotechnology Research industry.

What technology does Epredia use?

Minus sign iconPlus sign icon
Epredia's tech stack includes Twitter AdsPower BISAPJD EdwardsJavaScriptPRINCE2AutoptimizeApache.

What is Epredia's email format?

Minus sign iconPlus sign icon
Epredia's email format typically follows the pattern of First.Last@epredia.com. Find more Epredia email formats with LeadIQ.

When was Epredia founded?

Minus sign iconPlus sign icon
Epredia was founded in 2019.

Epredia

Biotechnology ResearchNew Hampshire, United States501-1000 Employees

Every second of every hour of every day, 44 of our products are employed in the battle against cancer. Customers put their trust in Epredia over a billion times every year. 

Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.

Today, we’re a global precision cancer diagnostics company working to improve patient outcomes by providing groundbreaking technologies. Since our humble beginnings in 1937, every product developed has been impacted by generations of employees who are committed to improving lives by enabling pathologists through enhancing precision cancer diagnostics.

Find out how you can improve lives while advancing your career at #Epredia by visiting epredia.com/careers. #WhatWeDoMatters

Section iconCompany Overview

Headquarters
20 Post Road Portsmouth, New Hampshire 03801 United States
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EPAM
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
501-1000

Section iconFunding & Financials

  • $500M$1B

    Epredia's revenue is estimated to be in the range of $500M$1B

Section iconFunding & Financials

  • $500M$1B

    Epredia's revenue is estimated to be in the range of $500M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.